le mie pubblicazioni

Abstract, poster e pubblicazioni scientifiche

• C. Pinnetti, P. Balestra, R. Libertone, P. Lorenzini, M. Ricottini, M.M.Plazzi, S Menichetti, V. Tozzi, A. Antinori and A. Ammassari: “Cardiovascular disease Framingham risk score (FRS) and VACS index are associated with neurocognitive impairment (NCI) in HIV-positive patients” - 14th European AIDS conference. Brussels, Belgium, 16-19 October 2013.
• R. Libertone, P. Balestra, P. Lorenzini, C. Pinnetti, M. Ricottini, S. Menichetti, M.M. Plazzi, A. Giannetti, V. Tozzi, A. Antinori, A. Ammassari: “APRI and FIB-4 scores are not associated with neuro cognitive impairment in HIV-infected persons” - VI Italian Conference on AIDS and Retroviruses. Roma, 25-27 May 2014. 
• R. Libertone, P. Lorenzini, P. Balestra, C. Pinnetti, M. Ricottini, M.M. Plazzi, S. Menichetti,  M. Zaccarelli, E. Nicastri, R. Bellagamba, A. Ammassari, A. Antinori: “Central nervous system penetration-effectiveness (CPE) rank does not reliably predict neurocognitive impairment in HIV-infected individuals” - “National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Clinical Department, Roma, Italy”
• G.Liuzzi, S.Menichetti, R.Libertone, MF Salvatori, P.Balestra, G.Orlando, G.Iacchetti, A.Antinori, V.Tozzi. Low risk of depression and anxiety in elderly HIV+ patients treated with Efavirenz. the World Congress on The Againg Male Tampa, FL, USA:
• G.Liuzzi, - S.Menichetti, R.Libertone, MF Salvatori, P.Balestra, G.Orlando, G.Iacchetti, A.Antinori, V.Tozzi. Basso rischio di depressione ed ansia nei pazienti anziani HIV+ in trattamento con Efavirenz. 6°Congresso Nazionale SIMIT Expo Napoli:
• V.Tozzi, P.Balestra, MF Salvatori, Chrysoula Vlassi, G.Liuzzi, S.Menichetti, M.Zaccarelli, S.Cerilli,  A.Antinori, P.Narciso. Changes in Cognition during HAART: comparison of two different scoring systems to measure antiretroviral drug efficacy on HIV-dementia. 15th Conference on Retroviruses and Opportunistic Infections, Boston
• G.Liuzzi, F.Continenza, A.Amendola, R.Libertone, S.Menichetti, C.Tommasi, R.Bellagamba, M.R.Capobianchi, V.Tozzi Relathionship between HIV-1 RNA Levels in plasma and semen in treated and untreated patients. 3º Congresso Nazionale Società Italiana Virologia Medica, CNR Roma
• G.Liuzzi, S.Menichetti, R.Libertone, MF Salvatori, P.Balestra, R. Bellagamba, A.Antinori, V.Tozzi – Factors associated with anxiety, depression and cognitive impairment in elderly patients receiving HAART 9th International Congress on Drug Therapy in HIV Infection Glasgow
• R. Libertone, A. Ammassari, P. Balestra, P. Lorenzini, C. Pinnetti, M. Ricottini, S. Menichetti, V. Tozzi, A.  Antinori Vitamin-D deficiency is associated with higher risk of neurocognitive impairment (NCI) in HIV-infected persons.
• Tozzi V, Balestra P, Lorenzini P, Libertone R, Picchi G, Zaccarelli M,  Liuzzi G, Sampaolesi A, Cataldo G, Menichetti S, Giulianelli M,  Narciso P, Antinori A. Neurocognitive profile of HIV associated neurococognitive disorders (HAND), 1996 to 2010: results from an observational cohort. Fourth International Meeting on HIV Infection and the Central Nervous System July, 15-16 2011 Frascati (Rome), Italy. 
• Balestra P, Tozzi V, Zaccarelli M, Libertone R, Cataldo G, Liuzzi G, Menichetti S, Giulianelli M,  Narciso P, Antinori A. Prevalence and risk factors for HIV associated neurococognitive disorders (HAND), 1996 to 2010: results from an observational cohort. 6th IAS Conference on pathogenesis, treatment and prevention, 17-20 July 2011 Rome
• Antinori, A; Balestra, P; Lorenzini, P; Libertone, R; Cataldo, G; D’Errico, D; Pascucci, T;  Menichetti, S; Ricottini, M e Tozzi, V Comparison of screening tools for the detection of neurocognitive impairment in HAART-treated patients
• G Liuzzi, S Menichetti, R Libertone, MF Salvatori, P Balestra, R Bellagamba, A Antinori, V Tozzi. Depression, Anxiety and cognitive impairmente in elderly patients receiving Haart: prevalce and risk factors Journal of the International AIDS Society, 2008
• Pinnetti C, Libertone R, Balestra P, Lorenzini P, Ricottini M, Menichetti S, Plazzi M, Zaccarelli M, Ammassari A, Antinori A. Declining prevalence of HIV-associated neurocognitive disorders in more recent years 22st Conference on Retroviruses and Opportunistic Infections. Seattle, 23-26 February 2015. (Abstract n° 63, oral presentation).
• Mondi A, Pinnetti C, Plazzi M, Abbate I, Rozera G, Libertone R, Menichetti S, Mazzotta V, Lorenzin P, Antinori
  Virological control in patients early switching versus maintaining initial antiretroviral therapy (ART) during primary HIV-1 infection (PHI): experience from an Italian cohort. Abstract ICAR 2017
• Pinnetti C, Menichetti S, Giannetti A, Ricottini M, Balestra P, Plazzi M,  Ottou S, Libertone R, Antinori A and Ammassari A.
  Sexual health (SH), adherence to antiretroviral therapy, and virologic suppression: a descriptive study in HIV sero-discordant couples (Passion Study). Abstract ICAR 2017
• Mastrorosa I, Pinnetti C, Lorenzini P, Balestra P, Libertone R, Ricottini M, Menichetti S, Plazzi MM,  Mazzotta V, Zaccarelli M, Ammassari A, Antinori A.
  Prevalence over time and predictive factors of HIV-associated neurocognitive disorder (HAND) in HIV-positive patients. 9th IAS Conference on HIV Science - Abstract Submission System
• Mastrorosa I, Pinnetti C, Lorenzini P, Brita AC, Libertone R, Menichetti S, Plazzi MM,   Mazzotta V, Vergori A, Cicalini S, Bellagamba R, Zaccarelli M, Antinori A
  Declining prevalence over time and factors associated to HIV-associated neurocognitive disorder (HAND) in ART-treated HIV-infected individuals.
  Abstract ICAR 2018 in fase di approvazione
• A.Mondi ,, C.Pinnetti, P. Lorenzini, M,M. Plazzi, I. Abbate, G. Rozera, C. Agrati, R. Libertone, S. Menichetti, I. Mastrorosa, A. Ammassari, A. Antinori
  Comparison of raltegravir (RAL) and boosted darunavir (DRV/b) versus dolutegravir (DTG) both associated with tenofovir/emtricitabine (TDF/FTC) in primary HIV infection (PHI): virological efficacy of two different integrase inhibitors (INSTI)-based treatment strategies.